Sr. Director, Sales Training at Definium Therapeutics

Job description

Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale. Our lead product candidate, lysergide tartrate (our proprietary orally disintegrating tablet form of lysergide (LSD) D-tartrate), represents a highly differentiated, potential best-in-class opportunity for patients suffering from generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Our early stage pipeline includes DT402, the R-enantiomer of MDMA and is under development to target the core symptoms of autism spectrum disorder (ASD), specifically addressing social communication challenges. Guided by the recognition that patients deserve more than better, Definium is relentlessly advancing a new generation of therapeutics intended to address the underlying causes of psychiatric and neurological disorders. By turning evidence into impact, Definium aims to change the trajectory of today’s mental health care crisis and enable a healthier future. Headquartered in New York, Definium Therapeutics trades on Nasdaq under the symbol DFTX. Together we are moving psychiatry forward—beyond better, into a boundless future. Join us! This is a high-impact, foundational leadership role reporting to the VP of Sales. You will own the end-to-end strategy and execution of sales training and capability development for a novel CNS product that will require deep scientific fluency, nuanced patient and HCP engagement, and rigorous compliance. You will shape how our future sales organization and adjacent commercial field teams master the science, the patient journey, competitive differentiation, and the unique considerations of bringing a novel psychedelic therapy to market. Success in this role will directly influence launch readiness, field force excellence, and long-term commercial performance. Location: Fully remote within the U.S., with frequent travel required. A significant portion of training delivery and team collaboration will occur at our Philadelphia office; therefore, candidates based in or near the Philadelphia area are strongly preferred. Responsibilities: Design and lead a comprehensive sales training curriculum covering product knowledge, clinical data, disease-state education (GAD, MDD), competitive landscape, objection handling, account management, and compliant promotional practices Build training programs tailored to the unique aspects of DT120 ODT, including administration considerations, clinical observation, patient selection, and the evolving regulatory and market access environment Partner closely with Commercial Leadership, Medical Affairs, Market Access, Compliance, and Legal to ensure training content is scientifically accurate, strategically aligned, and fully compliant Develop and deliver high-impact live, virtual, and digital training experiences for new-hire onboarding, ongoing skill development, launch readiness, and continuous learning— with substantial in-person delivery expected at the Philadelphia office and other locations as needed Lead the sales training function, leveraging external partners and vendors as needed to deliver high-quality programs; establish best-in-class processes, tools, and metrics for training effectiveness and field capability Create measurement frameworks to assess knowledge retention, behavioral change, and business impact; use data and field feedback to continuously refine programs Support sales leadership in coaching frameworks, performance management, and the development of sales managers as trainers and coaches. Drive a culture of excellence, curiosity, and patient-centricity across the commercial organization Contribute to broader commercial readiness planning and serve as a key voice on field capability needs Qualifications: Bachelor’s degree required; advanced degree (MBA, life sciences, education, or relate